Premium
Measurement of Low‐Density Lipoprotein Cholesterol in Assessment and Management of Cardiovascular Disease Risk
Author(s) -
Jialal I,
Remaley A T
Publication year - 2014
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2014.69
Subject(s) - cholesterol , clinical pharmacology , medicine , lipoprotein , disease , low density lipoprotein , intensive care medicine , cardiology , pharmacology
The deposition of cholesterol in the arterial wall by the infiltration of low‐density lipoproteins (LDLs) is a key step in the development of atherosclerosis. In this Commentary, we discuss recent recommendations for clinical laboratory measurement of low‐density lipoprotein cholesterol (LDL‐C) and its utility both for assessing cardiovascular disease risk and as a tool in the management of patients receiving lipid‐lowering therapy. Clinical Pharmacology & Therapeutics (2014); 96 1, 20–22. doi: 10.1038/clpt.2014.69